BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 15140415)

  • 1. Airway mucus hypersecretion in asthma: an undervalued pathology?
    Rogers DF
    Curr Opin Pharmacol; 2004 Jun; 4(3):241-50. PubMed ID: 15140415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary mucus: Pediatric perspective.
    Rogers DF
    Pediatr Pulmonol; 2003 Sep; 36(3):178-88. PubMed ID: 12910578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of airway mucus hypersecretion.
    Rogers DF; Barnes PJ
    Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
    Lai H; Rogers DF
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucus and MUC in asthma.
    Morcillo EJ; Cortijo J
    Curr Opin Pulm Med; 2006 Jan; 12(1):1-6. PubMed ID: 16357571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy.
    Lai HY; Rogers DF
    Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):67-76. PubMed ID: 19907312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucin-producing elements and inflammatory cells.
    Jeffery P; Zhu J
    Novartis Found Symp; 2002; 248():51-68; discussion 68-75, 277-82. PubMed ID: 12568488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.
    Rogers DF
    Monaldi Arch Chest Dis; 2000 Aug; 55(4):324-32. PubMed ID: 11057087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural changes in the airways in asthma: observations and consequences.
    Bai TR; Knight DA
    Clin Sci (Lond); 2005 Jun; 108(6):463-77. PubMed ID: 15896192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.
    Ishikawa Y; Yoshimoto T; Nakanishi K
    Int Immunol; 2006 Jun; 18(6):847-55. PubMed ID: 16611648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease.
    Mauad T; Dolhnikoff M
    Curr Opin Pulm Med; 2008 Jan; 14(1):31-8. PubMed ID: 18043273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory tract mucin genes and mucin glycoproteins in health and disease.
    Rose MC; Voynow JA
    Physiol Rev; 2006 Jan; 86(1):245-78. PubMed ID: 16371599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of concentrated ambient particles on normal and hypersecretory airways in rats.
    Harkema JR; Keeler G; Wagner J; Morishita M; Timm E; Hotchkiss J; Marsik F; Dvonch T; Kaminski N; Barr E
    Res Rep Health Eff Inst; 2004 Aug; (120):1-68; discussion 69-79. PubMed ID: 15543855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucous hypersecretion and relationship to cough.
    Nadel JA
    Pulm Pharmacol Ther; 2013 Oct; 26(5):510-3. PubMed ID: 23434445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options.
    Rogers DF
    COPD; 2005 Sep; 2(3):341-53. PubMed ID: 17146999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory Diseases.
    Ha EV; Rogers DF
    Pharmacology; 2016; 97(1-2):84-100. PubMed ID: 26674354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.